Search research articles
Contact Us
Filters
Showing results (1-10 of 192) with videos related to
Page
of 20
Sort By:
European Urology
|
April 28, 2015
Re: Byron H. Lee, Adam S. Kibel, Jay P. Ciezki, et al. Are biochemical recurrence outcomes similar after radical prostatectomy and radiation therapy? Analysis of prostate cancer-specific mortality by nomogram-predicted risks of biochemical recurrence. Eur Urol 2015;67:204-9
Kevin Lu
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 22, 2015
Depth of Invasion in High-Grade T1 Bladder Cancer: Added Value In Timely Cystectomy?
Kevin Lu
European Urology
|
April 14, 2015
Re: Arun A. Azad, Bernhard J. Eigl, Raya Leibowitz-Amit, et al. Outcomes with abiraterone acetate in metastatic castration-resistant prostate cancer patients who have poor performance status. Eur Urol 2015;67:441-7
Kevin Lu
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 3, 2015
Surveillance for Stage I Nonseminoma Testicular Cancer: Outcomes and Long-Term Follow-Up in a Population-Based Cohort
Kevin Lu
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 29, 2015
The Negative Is Not So Negative: What Do We Learn From Trials With Orteronel?
Kevin Lu
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 29, 2015
Older Men With Locally Advanced Prostate Cancer: To Treat or Not to Treat?
Kevin Lu
European Urology
|
August 31, 2015
Re: Orazio Caffo, Ugo De Giorgi, Lucia Fratino, et al. Clinical Outcomes of Castration-resistant Prostate Cancer Treatments Administered as Third or Fourth Line Following Failure of Docetaxel and Other Second-line Treatment: Results of an Italian Multicentre Study. Eur Urol 2015;68:147-53
Kevin Lu
The Lancet. Oncology
|
March 11, 2015
Adjuvant chemotherapy in locally advanced bladder cancer
Kevin Lu
Translational Lung Cancer Research
|
July 10, 2023
Intracranial responses with selective <i>KRAS</i>-G12C inhibitors in non-small cell lung cancer
Kevin Lu, Hatim Husain
Journal of Thoracic Disease
|
June 13, 2022
Intratumoral and intertumoral heterogeneity drives EGFR treatment considerations
Kevin Lu, Hatim Husain
Page
of 20
Search research articles
Search
Showing results (1-10 of 192) with videos related to
Sort By:
Page
of 20
European Urology
|
April 28, 2015
Re: Byron H. Lee, Adam S. Kibel, Jay P. Ciezki, et al. Are biochemical recurrence outcomes similar after radical prostatectomy and radiation therapy? Analysis of prostate cancer-specific mortality by nomogram-predicted risks of biochemical recurrence. Eur Urol 2015;67:204-9
Kevin Lu
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 22, 2015
Depth of Invasion in High-Grade T1 Bladder Cancer: Added Value In Timely Cystectomy?
Kevin Lu
European Urology
|
April 14, 2015
Re: Arun A. Azad, Bernhard J. Eigl, Raya Leibowitz-Amit, et al. Outcomes with abiraterone acetate in metastatic castration-resistant prostate cancer patients who have poor performance status. Eur Urol 2015;67:441-7
Kevin Lu
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 3, 2015
Surveillance for Stage I Nonseminoma Testicular Cancer: Outcomes and Long-Term Follow-Up in a Population-Based Cohort
Kevin Lu
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 29, 2015
The Negative Is Not So Negative: What Do We Learn From Trials With Orteronel?
Kevin Lu
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 29, 2015
Older Men With Locally Advanced Prostate Cancer: To Treat or Not to Treat?
Kevin Lu
European Urology
|
August 31, 2015
Re: Orazio Caffo, Ugo De Giorgi, Lucia Fratino, et al. Clinical Outcomes of Castration-resistant Prostate Cancer Treatments Administered as Third or Fourth Line Following Failure of Docetaxel and Other Second-line Treatment: Results of an Italian Multicentre Study. Eur Urol 2015;68:147-53
Kevin Lu
The Lancet. Oncology
|
March 11, 2015
Adjuvant chemotherapy in locally advanced bladder cancer
Kevin Lu
Translational Lung Cancer Research
|
July 10, 2023
Intracranial responses with selective <i>KRAS</i>-G12C inhibitors in non-small cell lung cancer
Kevin Lu, Hatim Husain
Journal of Thoracic Disease
|
June 13, 2022
Intratumoral and intertumoral heterogeneity drives EGFR treatment considerations
Kevin Lu, Hatim Husain
Page
of 20